Molecular Genetics of Rhizobium Nodulation Plasmids
根瘤菌结瘤质粒的分子遗传学
基本信息
- 批准号:7861402
- 负责人:
- 金额:$ 40.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-16 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AnabolismAntibioticsBacteriaBacterial GenesBacterial PhysiologyBiochemicalBiochemical GeneticsBiological AssayBioterrorismBrucellaCellsChemicalsChronicCyclic AMPDefectDetergentsDrug Delivery SystemsDrug resistanceEnzyme TestsEnzymesGenesGeneticGenomeGoalsHomologous GeneInfectionLipopolysaccharidesMammalsManganeseMedicago truncatulaMelilotusMembraneMicroarray AnalysisModificationMolecularMolecular GeneticsNatureNonhomologous DNA End JoiningOxidative StressPathogenesisPathway interactionsPhysiologicalPlant GenesPlantsPlasmidsPlayProtein SecretionProteinsProteomeRNA InterferenceResearchResearch PersonnelRhizobiumRoleScreening procedureSignal TransductionSinorhizobium melilotiSuperoxide DismutaseSuperoxidesSymbiosisTestingVitamin B 12Walkersbasecrosslinkdeoxycholategene functioninsightmutantnovelpathogenprogramsresponsesuccinoglycan
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this research is to develop a detailed, integrated view of how Sinorhizobium meliloti establishes the chronic intracellular infection that underlies symbiosis and to use these findings to gain new insights into molecular mechanisms used by chronic intracellular pathogens of mammals. This research is suggesting possible new drug targets for Brucella, a serious, hard-to-treat pathogen and a bioterrorism threat, offering detailed insights into the roles of lipopolysaccharides and exopolysaccharides in bacterial interactions with their eukaryotic hosts, and also helping elucidate the unknown part of vitamin B12 biosynthesis. We will continue to investigate the biosynthesis and function of vitamin B12 in S. meliloti by analyzing the 5,6-dimethylbenzimidazole biosynthetic pathway and investigating which B12-dependent enzymes are of symbiotic importantance in S. meliloti. We will continue to investigate CbrA, a previously unrecognized master regulator of symbiosis, including identifying regulatory targets through microarray analysis, determining the basis of detergent-sensitivity of cbrA mutants, and determining the role of the Brucella CbrA homolog in pathogenesis. We will determine the molecular basis of the interactions between symbiotically active rhizobial exopolysaccharides and the plant host by utilizing M. truncatula microarrays to identify plant genes regulated in response to succinoglycan and then dissecting the function of these genes using RNAi knockdowns and other approaches. We will continue to investigate the importance of lipopolysaccharide modifications for symbiosis and with a focus on BacA, including comparing plant responses to bacA mutants to that of a succinoglycan-deficient mutant, determining the topology of BacA protein, and screening for proteins that interact with BacA. We will continue to investigate the role of manganese in oxidative stress protection and symbiosis by further characterizing control of superoxide dismutase levels by manganese, investigating additional factors in superoxide sensitivity, testing the possible symbiotic importance of other Mn2+dependent enzymes, and testing the importance of non-homologous end-joining for symbiosis. We will determine the biochemical and physiological function of pmh, a highly conserved bacterial gene and a possible new drug target whose inactivation greatly sensitizes cells to numerous antibiotics that are no longer clinically useful because of acquired drug resistance.
描述(由申请人提供):本研究的长期目标是开发一个详细的,综合的观点,苜蓿中华根瘤菌如何建立慢性细胞内感染的基础共生,并使用这些发现获得新的见解,由哺乳动物的慢性细胞内病原体的分子机制。这项研究为布鲁氏菌提出了可能的新药靶点,布鲁氏菌是一种严重的,难以治疗的病原体和生物恐怖主义威胁,为脂多糖和胞外多糖在细菌与真核宿主相互作用中的作用提供了详细的见解,并有助于阐明维生素B12生物合成的未知部分。我们将继续研究维生素B12在S.通过分析5,6-二甲基苯并咪唑的生物合成途径和研究B12依赖的酶在苜蓿根瘤菌中的共生重要性。苜蓿草。我们将继续调查CbrA,一个以前未被认识的主调节共生,包括通过微阵列分析确定监管目标,确定基础的洗涤剂敏感性的cbrA突变体,并确定布鲁氏菌CbrA同源物的发病机制中的作用。我们将利用M.利用蒺藜微阵列来鉴定响应琥珀聚糖的植物基因,然后使用RNAi敲除和其他方法来剖析这些基因的功能。我们将继续研究脂多糖修饰对共生的重要性,重点是巴卡,包括比较植物对巴卡突变体和琥珀聚糖缺陷突变体的反应,确定巴卡蛋白的拓扑结构,并筛选与巴卡相互作用的蛋白质。我们将继续研究锰在氧化应激保护和共生中的作用,通过进一步表征锰对超氧化物歧化酶水平的控制,研究超氧化物敏感性的其他因素,测试其他Mn 2+依赖酶的可能共生重要性,并测试非同源末端连接对共生的重要性。我们将确定pmh的生化和生理功能,pmh是一种高度保守的细菌基因,也是一种可能的新药靶点,它的失活极大地使细胞对许多抗生素敏感,而这些抗生素由于获得性耐药性而不再有临床用途。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GRAHAM C WALKER其他文献
GRAHAM C WALKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GRAHAM C WALKER', 18)}}的其他基金
相似海外基金
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 40.78万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 40.78万 - 项目类别:
Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
- 批准号:
DP230102150 - 财政年份:2023
- 资助金额:
$ 40.78万 - 项目类别:
Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
- 批准号:
468567 - 财政年份:2022
- 资助金额:
$ 40.78万 - 项目类别:
Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 40.78万 - 项目类别:
Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10708102 - 财政年份:2022
- 资助金额:
$ 40.78万 - 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10587015 - 财政年份:2022
- 资助金额:
$ 40.78万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10581945 - 财政年份:2021
- 资助金额:
$ 40.78万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10358855 - 财政年份:2021
- 资助金额:
$ 40.78万 - 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
- 批准号:
2599490 - 财政年份:2021
- 资助金额:
$ 40.78万 - 项目类别:
Studentship














{{item.name}}会员




